ProCE Banner Activity

CE / CME

Atopic Dermatitis and Prurigo Nodularis: Mastering the Long Game in Itch

Video

On-demand webcast of expert faculty presentation and patient case discussion on the treatment of chronic itch in patients with atopic dermatitis or prurigo nodularis.

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Released: May 16, 2025

Expiration: May 15, 2026

Share

Provided by

Provided by Partners for Advancing Clinical Education (Partners), in partnership with the Coalition of Skin Diseases (CSD)

ProCE Banner

Supporters

Supported by educational grants from Sanofi and Regeneron Pharmaceuticals, and Incyte.

Incyte

Regeneron Pharmaceuticals

Sanofi

Partners

Coalition of Skin Diseases (CSD)

ProCE Banner

Target Audience

This educational activity is intended for dermatology nurse practitioners and physician associates, as well as those practicing in primary care, who are engaged in the care of patients with atopic dermatitis and prurigo nodularis.

Program Learning Goal

The goal of this activity is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Atopic Dermatitis

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Describe the impact of pruritus on the overall burden of living with AD and PN, highlighting its effects on patient quality of life, disease progression, and the challenges in effective management

  • Incorporate evidence-based tools for the measurement and assessment of itch into clinical practice to enhance patient care and treatment outcomes

  • Develop treatment plans for patients with AD and PN that take into consideration evidence for new and emerging therapies targeting neuroinflammation and itch

Disclosure

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships. 

Primary Author

Victoria Garcia-Albea, PNP, DCNP: consultant/advisor/speaker: Dermavant, Johnson & Johnson, Sanofi/Genzyme, Sun Pharma, UCB.

Martha L. Sikes, DMSc, RPh, PA-C: consultant/advisor/speaker: Ortho Dermatologics.

Heather Woolery-Lloyd, MD: consultant/advisor/speaker: AbbVie, Arcutis, Beiersdorf, Galderma, Incyte, Kenvue, Loreal, Ortho Dermatologics, Pfizer, Proctor and Gamble, SC Johnson, Unilever; researcher: AbbVie, Allergan, Arcutis, Avita, Eirion, Galderma, Pfizer, Teoxane Laboratories.

Kelly Barta: consultant/advisor/speaker: Astria Therapeutics​

Brindley Brooks: other financial or material support: Incyte, Lilly, Moonlake, Novartis, Sanofi, UCB 

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from May 16, 2025, through May 15, 2026:

  1. Login or Sign Up for an account by clicking at the top of this page.

  2. Read the target audience, learning objectives, and faculty disclosures.

  3. View and study the content in its entirety.

  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Learners have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and the Coalition of Skin Diseases (CSD). Partners for Advancing Clinical Education (Partners) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours, including 0.5 hours of pharmacotherapy credit.

Physician Associate Continuing Medical Education

Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until May 15, 2026. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation 
IPCE, Picture

This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credit for learning and change.